Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Cellebrite DI Ltd.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Cellebrite DI Ltd. (CLBT) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellebrite DI Ltd. (“Cellebrite” or “the Company”) (NASDAQ: CLBT). Investors who purchased Cellebrite securities are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether Cellebrite has violated federal securities laws.
What Potential Securities Violations Is BG&G Investigating?
On August 13, 2026, Cellebrite reported its financial results for the second quarter of 2026. Among other items, Cellebrite disclosed Annual Recurring Revenue (“ARR”) that missed the bottom end of its prior guidance. The Company also lowered its full-year ARR guidance and announced the abrupt replacement of CEO Tom Hogan. Following this news, Cellebrite’s stock price dropped $4.45 per share, or 29.18%, to close at $10.80 on August 13, 2026.
What Should Cellebrite DI Ltd. (CLBT) Investors Do?
If you are aware of any facts relating to this investigation or purchased Cellebrite securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
How Is Cellebrite DI Ltd. (NASDAQ: CLBT) Stock Trading Today?
Interactive chart showing the weekly share price history of CLBT (CLBT).
How Does BG&G Help Investors in Securities Fraud Investigations?
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”